Spanish Red Biotech Pipeline

MSD

Pembrolizumab / Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in combination w/concurrent chemoradiation therapy followed by Pembrolizumab w/or w/o Olaparib,compared to concurrent chemoradiation therapy alone in participants w/newly diagnosed treatment-Naïve limited-Stage Small Cell Lung Cancer(LS-SCL
Phase: 3Phase III in Spain, 2Phase II, 1Phase I